Metabolic Syndrome Among Inpatients With Schizophrenia: Prevalence and Clinical Correlates
Alpha Psychiatry · 16.10.2026 · 27 (5)
DOI: 10.31083/ap56362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alpha Psychiatry, online erschienen am 16.10.2026. Verfasst von Mao Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Affiliated Wuhan Mental Health Center, Tongji Medical College of Huazhong University of Science and Technology, 430012 Wuha…. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Commission of Hubei Province Scientific Research Project.
Abstract (Originalsprache)
Background
Metabolic syndrome (MetS) is a major physical comorbidity in schizophrenia and is associated with increased risks of cardiovascular disease, diabetes, and poor prognosis. This study investigated the prevalence of MetS and its clinical correlates among Chinese inpatients with schizophrenia, with particular attention to the metabolic-risk profiles of antipsychotic regimens.
Methods
This multicenter cross-sectional study included 1024 inpatients with schizophrenia from two tertiary psychiatric hospitals in Central China. MetS was diagnosed according to the criteria of the Chinese Diabetes Society. Sociodemographic, clinical, medication, physical examination, and laboratory data were collected. Antipsychotic regimens were classified as non-high-risk, high-risk, or high-risk-plus-low-risk combinations. Multivariable logistic regression was used to identify factors independently associated with MetS.
Results
Overall, 398 of 1024 patients met the criteria for MetS, yielding a prevalence of 38.9% (95% confidence interval (CI), 35.9%–41.9%). Compared with patients without MetS, those with MetS were more likely to be male, older, have a higher body mass index, have a longer illness duration, exhibit depressive symptoms, report a history of smoking and alcohol use, and have greater illness severity. In the multivariable analysis, male sex (adjusted odds ratio [aOR] = 1.65, 95% CI, 1.21–2.25), older age (aOR = 1.02, 95% CI, 1.00–1.03), illness duration >5 years (aOR = 1.55, 95% CI, 1.14–2.13), Calgary Depression Scale for Schizophrenia (CDSS)-defined depressive symptoms (aOR = 2.71, 95% CI, 1.87–3.92), and high-risk antipsychotic regimens (aOR = 1.54, 95% CI, 1.15–2.06) were independently associated with MetS. High-risk-plus-low-risk combination regimens and chlorpromazine-equivalent (CPZ-eq) dose were not significantly associated with MetS.
Conclusions
MetS is highly prevalent in this sample of Chinese inpatients with schizophrenia. The findings highlight the associations of both patient-level characteristics and antipsychotic regimen composition with MetS, whereas the current CPZ-equivalent dose showed no significant association. Enhanced metabolic monitoring and individualized treatment strategies are warranted in inpatient schizophrenia care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Affiliated Wuhan Mental Health Center, Tongji Medical College of Huazhong University of Science and Technology, 430012 Wuhan, Hubei, China.
- Research Center for Psychological and Health Sciences, China University of Geosciences, 430074 Wuhan, Hubei, China.
- Department of Psychiatry, Wuhan Wudong Hospital (Wuhan Second Mental Hospital), 430084 Wuhan, Hubei, China.
- Department of Psychiatry, Wuhan Mental Health Center, 430012 Wuhan, Hubei, China.
- Hubei Clinical Research Center for Whole-Course Management of Late-Life Mental Disorders, 430012 Wuhan, Hubei, China.
ORCID-Profile: Mao Tang, She-Hui Chang, Hang Qian, Bao-Liang Zhong
Förderung
- Health Commission of Hubei Province Scientific Research Project
Zitieren
APA
Tang, M., Chang, S. H., Qian, H., Zhang, C. Y., & Zhong, B. L. (2026). Metabolic Syndrome Among Inpatients With Schizophrenia: Prevalence and Clinical Correlates. Alpha Psychiatry, 27(5). https://doi.org/10.31083/ap56362
Vancouver
Tang M, Chang SH, Qian H, Zhang CY, Zhong BL. Metabolic Syndrome Among Inpatients With Schizophrenia: Prevalence and Clinical Correlates. Alpha Psychiatry. 2026;27(5). doi:10.31083/ap56362
BibTeX
@article{Tang2026,
author = {Tang, Mao and Chang, She-Hui and Qian, Hang and Zhang, Chang-Yong and Zhong, Bao-Liang},
title = {Metabolic Syndrome Among Inpatients With Schizophrenia: Prevalence and Clinical Correlates},
journal = {Alpha Psychiatry},
year = {2026},
volume = {27},
number = {5},
doi = {10.31083/ap56362}
}
EUVIMED